Introduction
Certain conditions can increase a patient’s risk of infection and pose additional risks during the recovery process. In the present case, HH, a 68-year-old man, is admitted to the ward with a diagnosis of community-acquired pneumonia. Aside from the symptoms of this infection, the patient has a history of chronic obstructive pulmonary disease (COPD), hypertension, hyperlipidemia, and diabetes. Each condition has its own outcomes on the man’s health and response to treatments. It is vital to consider the patient’s current needs and future actions to continue improving his condition.
Health Needs
The most urgent health need that HH experiences is the continuation of his pneumonia treatment. Although the patient shows positive changes in his oxygen requirements, the treatment with antibiotics should not be stopped prematurely (Metlay et al., 2019). Thus, the main goal is to determine the following steps for addressing his infection.
Second, it is unclear whether the patient’s other conditions are controlled with medication. In particular, a concerning issue is the history of COPD, as it is linked to the increased risk of pneumonia and its long-lasting complications on the patient’s breathing (Hartley et al., 2020). The connection between diabetes and pneumonia is not supported by evidence, but a discussion about disease management should also occur. Thus, one must inquire about the medications the patient is currently taking and whether he experiences any other symptoms unrelated to his pneumonia diagnosis.
Another patient need is connected to the man’s symptoms of nausea and vomiting and his inability to tolerate a diet. These problems are common in patients taking antibiotics, as these are frequently occurring side effects (Rosenthal & Burchum, 2021). Thus, the patient does not appear to be in an urgent situation that requires significant changes to his treatment. Nevertheless, as HH is in distress, this concern should be addressed to ensure recovery. Additionally, as the patient has diabetes, not eating may lead to problems with glucose levels in the blood, exposing HH to other adverse health outcomes (Brunetti et al., 2021). Strategies to address this problem may range from pharmacological interventions to changes in patient behavior when taking antibiotics.
Type of Treatment Regimen
Based on the discussed health needs, the patient’s treatment regimen should not be changed significantly in the following days. First, HH needs to complete the prescribed antibiotics in the correct dosage and duration to ensure the infection is fully treated. The course of therapy typically lasts from 4 to 10 days, depending on the severity of the condition (Metlay et al., 2019).
The patient should remain on ceftriaxone and azithromycin for at least one or two days before reviewing changes in his symptoms. It is possible to switch the patient’s azithromycin from IV to oral tablet form for seven days, 500 mg once daily (Metlay et al., 2019). This change may help alleviate the patient’s nausea and increase their comfort.
If HH continues to experience vomiting, and it significantly impairs his treatment, additional measures should be taken. For instance, the patient’s water intake has to be analyzed – it is possible that the patient does not drink enough fluids. One may consider prescribing HH with antiemetics, but common drugs such as domperidone are not advised for use in combination with hypertension or antibiotic treatment (Rosenthal & Burchum, 2021). Thus, a small dose of ondansetron may be considered as an option with close monitoring of the patient’s symptoms. The patient may be more comfortable with a slow-release 8mg tablet taken twice daily for two days (Rosenthal & Burchum, 2021).
If the patient experiences nausea that continues to disrupt his diet and leads to serious complaints, the drug therapy can be altered. An alternative to the prescribed antibiotics is moxifloxacin administered intravenously at 400 mg for seven days (Rosenthal & Burchum, 2021). However, the nausea will likely pass as soon as the patient finishes the course of antibiotics.
Patient Education Strategy
The patient education should focus on talking to the patient about his medical history, switching from IVs to tablets, and ways to deal with nausea without additional drugs. First, one must establish whether the patient controls his hypertension, diabetes, and other conditions. This information helps adjust the plan in the future, if necessary.
Second, the patient should be instructed to take antibiotics at the same time every day and with a glass of water before meals (Metlay et al., 2019). These steps may also help alleviate symptoms of nausea and vomiting, aiding in the patient’s recovery. HH may also be advised to sip water or other liquids throughout the day and eat smaller portions of food.
Conclusion
In conclusion, the patient’s case presents several challenges for the provider. The multitude of other conditions exposes the patient to potentially harmful outcomes and requires one to consider medication interactions. To effectively design a treatment regimen, the healthcare professional must inquire about the patient’s current medications.
Furthermore, the patient’s health needs to deal with nausea, which is common in antibiotic treatment, but it is still uncomfortable for the patient. Thus, HH may be prescribed antiemetics and advised on how to lower the risk of nausea with hydration and meal size. Preparing the patient for new drug treatments is also a part of the education plan.
References
Brunetti, V. C., Ayele, H. T., Yu, O. H. Y., Ernst, P., & Filion, K. B. (2021). Type 2 diabetes mellitus and risk of community-acquired pneumonia: A systematic review and meta-analysis of observational studies. Canadian Medical Association Open Access Journal, 9(1), E62-E70.
Hartley, B. F., Barnes, N. C., Lettis, S., Compton, C. H., Papi, A., & Jones, P. (2020). Risk factors for exacerbations and pneumonia in patients with chronic obstructive pulmonary disease: A pooled analysis. Respiratory Research, 21, 1-10.
Metlay, J. P., Waterer, G. W., Long, A. C., Anzueto, A., Brozek, J., Crothers, K., Cooley, L., Dean, N., Fine, M., Flanders, S., Griffin, M., Metersky, M., Musher, D., Restrepo, M., & Whitney, C. G. (2019). Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America. American Journal of Respiratory and Critical Care Medicine, 200(7), e45-e67.
Rosenthal, L. D., & Burchum, J. R. (2021). Lehne’s pharmacotherapeutics for advanced practice nurses and physician assistants (2nd ed.) Elsevier.